Lutetium ethylenediaminetetramethylene phosphonate is a radiopharmaceutical commonly used for its analgesic effect in patients with bone cancer, and relaxin inhibits the Notch‐1 pathway in OS cells through the Notch‐1 pathway.242. The gene discussed is NOTCH1; the disease is bone cancer.